Valuation · at the close on 16 Oct 2026

Abbott Laboratories (Pakistan) Limited (ABOT) valuation

At Rs 944.39 (close on 16 Oct 2026) ABOT trades at 10.8× earnings (TTM to Jun 2026), below its five-year average of 47.0× and below the Pharmaceuticals median of 12.5×. The shares are priced at 2.88× book value (sector median 3.14×). Enterprise value of Rs 79.6 bn is 5.1× EBITDA. The dividend yield is 4.2%, against a five-year average of 2.3%.

P/E · today

10.8×

TTM to Jun 2026

5-yr average47.0× Sector median12.5×

P/B · today

2.88×

Quarter to Jun 2026

5-yr average3.56× Sector median3.14×

EV/EBITDA · today

5.1×

5-yr average7.3× Sector median6.7×

Dividend yield · today

4.2%

FY2025

5-yr average2.3% Payers' median4.6%

Market value Rs 92.5 bn at Rs 944.39. Sector medians use the latest close of 14 Pharmaceuticals companies; P/E and P/B only where earnings / book value are positive; the yield median covers dividend payers only. Not investment advice.

Valuation history

At each fiscal year-end price.

5 10 All

ABOT valuation history (annual) (Rs bn)

Rs bn	FY2025 Jan – Dec 2025	FY2024 Jan – Dec 2024	FY2023 Jan – Dec 2023	FY2022 Jan – Dec 2022	FY2021 Jan – Dec 2021	FY2020 Jan – Dec 2020	FY2019 Jan – Dec 2019	FY2018 Jan – Dec 2018	FY2017 Jan – Dec 2017	FY2016 Jan – Dec 2016	FY2015 Jan – Dec 2015	FY2014 Jan – Dec 2014	FY2013 Jan – Dec 2013	FY2012 Jan – Dec 2012	FY2011 Jan – Dec 2011	FY2010 Jan – Dec 2010	FY2009 Dec 2008 – Nov 2009	FY2008 Dec 2007 – Nov 2008	FY2007 Dec 2006 – Nov 2007	FY2006 Dec 2005 – Nov 2006
Market capitalisation	102.8	121.2	45.1	45.4	70.2	74.0	43.7	61.8	68.3	93.7	62.2	69.6	38.5	22.5	9.8	10.7	9.4	10.8	20.2	14.1
Enterprise value	90.0	115.1	40.2	36.8	61.8	67.3	41.4	56.3	59.7	85.8	53.8	63.2	34.6	19.7	8.3	9.9	8.7	9.7	19.1	12.5
Share price (period end) Rs	1,050.14	1,237.86	460.21	463.31	717.51	755.37	446.78	631.05	697.61	957.09	635.00	710.68	393.50	229.50	99.79	109.74	96.49	110.00	206.50	144.00
P/E (diluted)	12.91×	23.15×	172.11×	15.10×	11.77×	16.31×	33.65×	22.93×	16.24×	23.30×	17.33×	24.70×	15.23×	10.75×	5.94×	9.13×	15.51×	31.31×	17.06×	17.79×
Price to book	3.25×	5.11×	2.47×	2.65×	4.05×	4.74×	3.27×	4.67×	4.76×	6.42×	4.80×	6.40×	4.40×	3.35×	1.88×	2.75×	2.92×	3.02×	5.48×	3.32×
Price to sales	1.36×	1.78×	0.81×	0.92×	1.65×	2.10×	1.45×	2.08×	2.62×	4.01×	2.94×	3.53×	2.24×	1.48×	0.75×	0.98×	1.12×	1.51×	3.07×	3.01×
EV / EBITDA	5.97×	10.78×	8.39×	4.88×	6.82×	9.33×	11.66×	11.03×	9.74×	14.91×	10.60×	14.65×	8.87×	6.10×	3.25×	3.14×	4.40×	5.49×	8.04×	9.84×
EV / Sales	1.19×	1.69×	0.72×	0.75×	1.45×	1.91×	1.37×	1.89×	2.29×	3.67×	2.54×	3.21×	2.01×	1.29×	0.64×	0.90×	1.03×	1.36×	2.90×	2.70×
Dividend yield (gross)	1.0%	0.0%	0.0%	7.6%	6.3%	3.0%	2.2%	6.3%	5.7%	3.1%	2.3%	1.0%	1.8%	3.1%	5.0%	4.6%	12.4%	4.5%	8.7%	1.2%
Free cash flow yield	7.7%	1.7%	(5.3%)	2.5%	9.0%	9.6%	(4.2%)	1.6%	6.6%	2.7%	5.4%	4.5%	4.6%	8.9%	11.3%	4.7%	9.2%	4.1%	6.1%	4.3%
PEG ratio	0.25×	0.01×	(1.89×)	(0.30×)	0.37×	0.07×	(0.65×)	(0.64×)	3.56×	1.92×	0.63×	2.17×	0.73×	0.40×	0.15×	0.10×	0.20×	(0.44×)	0.34×	(0.57×)
P/E (diluted, normalised)	12.36×	22.20×	172.11×	15.10×	11.77×	16.31×	33.36×	22.93×	16.18×	23.30×	17.33×	24.70×	15.23×	10.75×	5.94×	9.13×	15.51×	31.31×	17.06×	17.79×
Price to book — 5-year average	3.56×	3.87×	3.41×	3.85×	4.30×	4.80×	4.81×	5.39×	5.40×	5.32×	4.55×	4.26×	3.27×	2.79×	3.11×	3.50×	3.55×	3.40×	3.01×	2.23×
EV / EBITDA — 5-year average	7.30×	8.18×	7.70×	8.12×	9.23×	11.19×	11.60×	12.09×	11.80×	11.54×	9.41×	7.91×	5.48×	4.44×	4.71×	5.68×	6.88×	7.03×	6.61×	5.91×
Dividend yield — 5-year average	2.3%	2.8%	4.0%	5.1%	4.8%	4.1%	4.0%	3.6%	2.9%	2.2%	2.0%	2.0%	3.9%	5.3%	7.2%	6.3%	5.9%	4.7%	4.7%	3.0%

ABOT valuation: frequently asked questions

What is ABOT's P/E ratio? +

At the closing price of Rs 944.39 on 16 Oct 2026, ABOT trades at a P/E of 10.8× based on EPS of Rs 87.47 (TTM to Jun 2026).

What is ABOT's book value per share? +

Abbott Laboratories (Pakistan) Limited's book value per share was Rs 323.04 at the end of FY2025. The shares trade at 2.88× book value.

Information only, not investment advice.